Skip to main content

Advertisement

SpringerLink
Log in

Esophageal Cancer: Whether and What Before or After Surgery?

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Esophageal cancer is the eighth most common cancer and the sixth most common cause of cancer-related mortality worldwide. Surgery has been the mainstay of the treatment of esophageal cancer. However, given the dismal survival with surgery alone, other modalities, e.g., chemotherapy (CT) and radiotherapy (RT), have been used for the management of these cancers. This review aims to look at the evolution of multi-modality management of esophageal cancer and tries to answer certain questions pertaining to the management of these cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sun X-D, Yu J-M, Fan X-L, Ren R-M, Li M-H, Zhang G-L (2006) Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest. Zhonghua Zhong Liu Za Zhi 28:784–787

    Google Scholar 

  2. Rice TW, Rusch VW, Apperson-Hansen C et al (2009) Worldwide esophageal cancer collaboration. Dis Esophagus 22:1–8. https://doi.org/10.1111/j.1442-2050.2008.00901.x

    Article  CAS  Google Scholar 

  3. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiat Therapy Oncol Group JAMA 281:1623–1627. https://doi.org/10.1001/jama.281.17.1623

    Article  CAS  Google Scholar 

  4. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP (2002) INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174. https://doi.org/10.1200/JCO.2002.20.5.1167

    Article  CAS  Google Scholar 

  5. Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147

    CAS  Google Scholar 

  6. Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, Gu XZ, Zhang DC, Zhang RG, Wang LJ (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331–336. https://doi.org/10.1016/s0003-4975(02)04401-6

    Article  Google Scholar 

  7. Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M (2010) Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5:244–250. https://doi.org/10.1097/JTO.0b013e3181c5e34f

    Article  Google Scholar 

  8. Ni W, Yu S, Xiao Z et al (2021) Postoperative adjuvant therapy versus surgery alone for stage IIB-III esophageal squamous cell carcinoma: a phase III randomized controlled trial. Oncologist 26:e2151–e2160. https://doi.org/10.1002/onco.13914

    Article  CAS  Google Scholar 

  9. Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 21:4592–4596. https://doi.org/10.1200/JCO.2003.12.095

    Article  Google Scholar 

  10. Armanios M, Xu R, Forastiere AA, Haller DG, Kugler JW, Benson AB, Eastern Cooperative Oncology Group (2004) Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group. J Clin Oncol 22:4495–4499. https://doi.org/10.1200/JCO.2004.06.533

    Article  CAS  Google Scholar 

  11. Bédard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R (2001) The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 91:2423–2430

    Article  Google Scholar 

  12. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Mason DP, Rodriguez CP, Ives DI (2009) Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 4:1264–1269. https://doi.org/10.1097/JTO.0b013e3181b26f8e

    Article  Google Scholar 

  13. Sato M, Ando N (2011) Neoadjuvant chemotherapy followed by surgery as standard treatment for stage II + III thoracic esophageal squamous cell carcinoma in Japan. Nihon Geka Gakkai Zasshi 112:104–110

    Google Scholar 

  14. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733. https://doi.org/10.1016/S0140-6736(02)08651-8

    Article  Google Scholar 

  15. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067. https://doi.org/10.1200/JCO.2009.22.2083

    Article  Google Scholar 

  16. Kelsen DP, Winter KA, Gunderson LL et al (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25:3719–3725. https://doi.org/10.1200/JCO.2006.10.4760

    Article  Google Scholar 

  17. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20. https://doi.org/10.1056/NEJMoa055531

    Article  CAS  Google Scholar 

  18. Ychou M, Boige V, Pignon J-P et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721. https://doi.org/10.1200/JCO.2010.33.0597

    Article  CAS  Google Scholar 

  19. Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Dalesio O, Buyse M, Duez N (1988) The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC. Recent Results Cancer Res 110:1–13. https://doi.org/10.1007/978-3-642-83293-2_1

    Article  CAS  Google Scholar 

  20. Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327. https://doi.org/10.1016/0360-3016(89)90323-4

    Article  CAS  Google Scholar 

  21. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJ, Mackillop WJ (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113. https://doi.org/10.1016/0167-8140(92)90287-5

    Article  CAS  Google Scholar 

  22. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167. https://doi.org/10.1056/NEJM199707173370304

    Article  CAS  Google Scholar 

  23. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092. https://doi.org/10.1200/JCO.2007.12.9593

    Article  CAS  Google Scholar 

  24. van Hagen P, Hulshof MCCM, van Lanschot JJB et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084. https://doi.org/10.1056/NEJMoa1112088

    Article  Google Scholar 

  25. Shapiro J, van Lanschot JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098. https://doi.org/10.1016/S1470-2045(15)00040-6

    Article  Google Scholar 

  26. Yang H, Liu H, Chen Y et al (2018) neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 36:2796–2803. https://doi.org/10.1200/JCO.2018.79.1483

    Article  CAS  Google Scholar 

  27. Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856. https://doi.org/10.1200/JCO.2008.17.0506

    Article  CAS  Google Scholar 

  28. Burmeister BH, Thomas JM, Burmeister EA, Walpole ET, Harvey JA, Thomson DB, Barbour AP, Gotley DC, Smithers BM (2011) Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 47:354–360. https://doi.org/10.1016/j.ejca.2010.09.009

    Article  Google Scholar 

  29. Klevebro F, Alexandersson von Döbeln G, Wang N et al (2016) A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Ann Oncol 27:660–667. https://doi.org/10.1093/annonc/mdw010

    Article  CAS  Google Scholar 

  30. Reynolds J, Preston S, O’Neill B et al (2017) ICORG 10–14: neoadjuvant trial in adenocarcinoma of the oesophagus and oesophagogastric junction international study (Neo-AEGIS). BMC Cancer 17:401. https://doi.org/10.1186/s12885-017-3386-2

    Article  CAS  Google Scholar 

  31. Hoeppner J, Lordick F, Brunner T et al (2016) ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286). BMC Cancer 16:503. https://doi.org/10.1186/s12885-016-2564-y

    Article  CAS  Google Scholar 

  32. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317. https://doi.org/10.1200/JCO.2005.00.034

    Article  Google Scholar 

  33. Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168. https://doi.org/10.1200/JCO.2005.04.7118

    Article  CAS  Google Scholar 

  34. Markar S, Gronnier C, Duhamel A, Pasquer A, Théreaux J, du Rieu MC, Lefevre JH, Turner K, Luc G, Mariette C (2015) Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option? J Clin Oncol 33:3866–3873. https://doi.org/10.1200/JCO.2014.59.9092

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Gastroenterology, Sahasra Hospitals, Jayanagar, Bangalore Karnataka, 560082, India

    Murugappan Nachiappan

  2. Department of Hepato-Pancreato-Biliary (HPB) Surgery, Mahatma Gandhi Medical College & Hospital (MGMCH), Jaipur Rajasthan, 302022, India

    V. K. Kapoor

Authors
  1. Murugappan Nachiappan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. K. Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. K. Kapoor.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nachiappan, M., Kapoor, V.K. Esophageal Cancer: Whether and What Before or After Surgery?. Indian J Surg Oncol 13, 880–887 (2022). https://doi.org/10.1007/s13193-022-01655-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-022-01655-y

Keywords

Search

Navigation